Role of farnesoid X receptor in cholestasis

被引:40
|
作者
Yuan, Zhi Qing [1 ]
Li, Ke Wei [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Biliary Pancreat Surg, 160 Pujian Rd, Shanghai 200127, Peoples R China
关键词
bile acid; cholestasis; enterohepatic circulation; farnesoid X receptor; hepatobiliary transport; ORGANIC SOLUTE TRANSPORTER; SALT EXPORT PUMP; BILE-ACID HOMEOSTASIS; CANALICULAR ABC TRANSPORTERS; ANIT-INDUCED HEPATOTOXITY; FXR-MEDIATED REGULATION; ALPHA-OST-BETA; NF-KAPPA-B; NUCLEAR RECEPTOR; DOWN-REGULATION;
D O I
10.1111/1751-2980.12378
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The nuclear receptor farnesoid X receptor (FXR) plays an important role in physiological bile acid synthesis, secretion and transport. Defects of FXR regulation in these processes can cause cholestasis and subsequent pathological changes. FXR regulates the synthesis and uptake of bile acid via enzymes. It also increases bile acid solubility and elimination by promoting conjugation reactions and exports pump expression in cholestasis. The changes in bile acid transporters are involved in cholestasis, which can result from the mutations of transporter genes or acquired dysfunction of transport systems, such as inflammation-induced intrahepatic cholestasis. The modulation function of FXR in extrahepatic cholestasis is not identical to that in intrahepatic cholestasis, but the discrepancy may be reduced over time. In extrahepatic cholestasis, increasing biliary pressure can induce bile duct proliferation and bile infarcts, but the absence of FXR may ameliorate them. This review provides an update on the function of FXR in the regulation of bile acid metabolism, its role in the pathophysiological process of cholestasis and the therapeutic use of FXR agonists.
引用
收藏
页码:501 / 509
页数:9
相关论文
共 50 条
  • [21] Arbutin Alleviates the Liver Injury of α-Naphthylisothiocyanate-induced Cholestasis Through Farnesoid X Receptor Activation
    Wu, Peijie
    Qiao, Ling
    Yu, Han
    Ming, Hui
    Liu, Chao
    Wu, Wenjun
    Li, Baixue
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [22] Farnesoid X receptor agonist tropifexor attenuates cholestasis in a randomised trial in patients with primary biliary cholangitis
    Schramm, Christoph
    Wedemeyer, Heiner
    Mason, Andrew
    Hirschfield, Gideon M.
    Levy, Cynthia
    Kowdley, Kris V.
    Milkiewicz, Piotr
    Janczewska, Ewa
    Malova, Elena Sergeevna
    Sanni, Johanne
    Koo, Phillip
    Chen, Jin
    Choudhury, Subhajit
    Klickstein, Lloyd B.
    Badman, Michael K.
    Jones, David
    JHEP REPORTS, 2022, 4 (11)
  • [23] Novel β-catenin/farnesoid X receptor interaction regulates hepatic bile acid metabolism during cholestasis
    Ehrlich, Laurent
    Glaser, Shannon S.
    HEPATOLOGY, 2018, 67 (03) : 829 - 832
  • [24] Yangonin protects against estrogen-induced cholestasis in a farnesoid X receptor-dependent manner
    Dong, Renchao
    Wang, Junqiao
    Gao, Xiaoguang
    Wang, Changyuan
    Liu, Kexin
    Wu, Jingjing
    Liu, Zhihao
    Sun, Huijun
    Ma, Xiaodong
    Meng, Qiang
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 857
  • [25] Mast Cells Regulate Ductular Reaction and Intestinal Inflammation in Cholestasis Through Farnesoid X Receptor Signaling
    Meadows, Vik
    Kennedy, Lindsey
    Ekser, Burcin
    Kyritsi, Konstantina
    Kundu, Debjyoti
    Zhou, Tianhao
    Chen, Lixian
    Pham, Linh
    Wu, Nan
    Demieville, Jennifer
    Hargrove, Laura
    Glaser, Shannon
    Alpini, Gianfranco
    Francis, Heather
    HEPATOLOGY, 2021, 74 (05) : 2684 - 2698
  • [26] Farnesoid X Receptor Regulation of the NLRP3 Inflammasome Underlies Cholestasis-Associated Sepsis
    Hao, Haiping
    Cao, Lijuan
    Jiang, Changtao
    Che, Yuan
    Zhang, Songyang
    Takahashi, Shogo
    Wang, Guangji
    Gonzalez, Frank J.
    CELL METABOLISM, 2017, 25 (04) : 856 - +
  • [27] Effects of corilagin on alleviating cholestasis via farnesoid X receptor-associated pathways in vitro and in vivo
    Yang, Fan
    Wang, Yao
    Li, Gang
    Xue, Juan
    Chen, Zhi-Lin
    Jin, Feng
    Luo, Lei
    Zhou, Xuan
    Ma, Qian
    Cai, Xin
    Li, Hua-Rong
    Zhao, Lei
    BRITISH JOURNAL OF PHARMACOLOGY, 2018, 175 (05) : 810 - 829
  • [28] Pharmacologic activation of hepatic farnesoid X receptor prevents parenteral nutrition-associated cholestasis in mice
    El Kasmi, Karim C.
    Ghosh, Swati
    Anderson, Aimee L.
    Devereaux, Michael W.
    Balasubramaniyan, Natarajan
    D'Alessandro, Angelo
    Orlicky, David J.
    Suchy, Frederick J.
    Shearn, Colin T.
    Sokol, Ronald J.
    HEPATOLOGY, 2022, 75 (02) : 252 - 265
  • [29] Mechanism and Active Components of Qingre Lidan Tablets Alleviate Intrahepatic Cholestasis by Activating the Farnesoid X Receptor
    Xia, Yafei
    Yan, Shixin
    Chang, Yang
    Yin, Jiaoyang
    Li, Hongyu
    Yan, Shu
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [30] Role of Farnesoid X Receptor (FXR) in control of plasma lipid levels
    Claudel, T
    Elzinga, BM
    Bloks, V
    Staels, B
    Voshol, PJ
    Kuipers, F
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 95 - 96